ZolpiMist is a sedative-hypnotic (sleep) medicine. ZolpiMist is used in adults
for the short-term treatment of a sleep problem called insomnia.

Who we are

Our website address is: https://myzolpimist.com.

What personal data we collect and why we collect it


When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection.

An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.


If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.

Contact forms


If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year.

If you have an account and you log in to this site, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser.

When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select “Remember Me”, your login will persist for two weeks. If you log out of your account, the login cookies will be removed.

If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.

Embedded content from other websites

Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website.

These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.


Who we share your data with

How long we retain your data

If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue.

For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information.

What rights you have over your data

If you have an account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.

Where we send your data

Visitor comments may be checked through an automated spam detection service.

Your contact information

Additional information

How we protect your data

What data breach procedures we have in place

What third parties we receive data from

What automated decision making and/or profiling we do with user data

Industry regulatory disclosure requirements


ZolpiMist (zolpidem tartrate) Oral Spray is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease sleep latency for up to 35 days in controlled clinical studies. The clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.


Complex sleep behaviors including sleep-walking, sleep-driving, and engaging in other activities while not fully awake may occur following use of ZolpiMist. Some of these events may result in serious injuries, including death. Discontinue ZolpiMist immediately if a patient experiences a complex sleep behavior.


What is the most important information I should know about ZolpiMist?
Complex sleep behaviors that have caused serious injury and death.
After taking ZolpiMist, you may get up out of bed while not being fully awake and do an activity that you do not know you are doing (complex sleep behaviors). The next morning, you may not remember that you did anything during the night. These activities may happen whether or not you drink alcohol or take other medicines that make you sleepy with ZolpiMist. Reported activities include:
  • driving a car (“sleep-driving”)
  • making and eating food
  • talking on the phone
  • having sex
  • sleep-walking
Stop taking ZolpiMist and call your doctor right away if you find out that you have done any of the above activities after taking ZolpiMist.
  1. Take ZolpiMist exactly as prescribed
    • Do not take more ZolpiMist than prescribed.
    • Take ZolpiMist right before you get in bed, not sooner.
  2. Do not take ZolpiMist if you:
    • have ever experienced a complex sleep behavior (such as driving a car, making and eating food, talking on the phone or having sex while not fully awake) after taking ZolpiMist
    • drink alcohol
    • take other medicines that can make you sleepy. Talk to your doctor about all of your medicines. Your doctor will tell you if you can take ZolpiMist with your other medicines.
    • cannot get a full night sleep
What is ZolpiMist?
ZolpiMist is a sedative-hypnotic (sleep) medicine. ZolpiMist is used in adults for the short-term treatment of a sleep problem called insomnia. Symptoms of insomnia include:
  • trouble falling asleep
ZolpiMist is not for children.
ZolpiMist is a federally controlled substance (C-IV) because it can be abused and lead to dependence. Keep ZolpiMist in a safe place to prevent misuse and abuse. Selling or giving away ZolpiMist may harm others and is against the law. Tell your doctor if you have ever abused or have been dependent on alcohol, prescription medicines, or street drugs.
Who should not take ZolpiMist?
Do not take ZolpiMist if you have had an allergic reaction to zolpidem (Ambien, Ambien CR, ZolpiMist). Some signs of allergic reaction may be swelling of the face, a feeling of the throat closing, or difficulty breathing shortly after taking Zolpidem.
See the end of this Medication Guide for a complete list of ingredients in ZolpiMist.
ZolpiMist may not be right for you. Before starting ZolpiMist, tell your doctor about all of your health conditions, including if you:
  • have a history of depression, mental illness, or suicidal thoughts
  • have a history of drug or alcohol abuse or addiction
  • have kidney or liver disease
  • have a lung disease or breathing problems
  • are pregnant, planning to become pregnant, or breastfeeding
Tell your doctor about all the medicines you take including prescription and nonprescription medicines, vitamins, and herbal supplements. Medicines can interact with each other, sometimes causing serious side effects.
Do not take ZolpiMist with other medicines that can make you sleepy.
Know the medicines you take. Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine.
How should I take ZolpiMist?
  • Take ZolpiMist exactly as prescribed. Do not take more ZolpiMist than prescribed for you.
  • Take ZolpiMist right before you get into bed.
  • Do not take ZolpiMist unless you are able to stay in bed a full night (7-8 hours) before you must be active again.
  • For faster sleep onset, ZolpiMist should NOT be taken with or immediately after a meal.
  • Call your doctor if your insomnia worsens or is not better within 7 to 10 days. This may mean that there is another condition causing your sleep problem.
  • If you take too much ZolpiMist or overdose, call your doctor or poison control center right away, or get emergency treatment.
What are the possible side effects of ZolpiMist?
Serious side effects of ZolpiMist include:
  • getting out of bed while not being fully awake and doing an activity that you do not know you are doing. (See “What is the most important information I should know about ZolpiMist?”)
  • abnormal thoughts and behavior. Symptoms include more outgoing or aggressive behavior than normal, confusion, agitation, hallucinations, worsening of depression, and suicidal thoughts or actions.
  • memory loss
  • anxiety
  • severe allergic reactions. Symptoms include swelling of the tongue or throat, trouble breathing, and nausea and vomiting. Get emergency medical help if you get these symptoms after taking ZolpiMist.
Call your doctor right away if you have any of the above side effects or any other side effects that worry you while using ZolpiMist.
The most common side effects of ZolpiMist are:
  • drowsiness
  • dizziness
  • diarrhea
  • “drugged feelings”
  • You may still feel drowsy the next day after taking ZolpiMist. Do not drive or do other dangerous activities after taking ZolpiMist until you feel fully awake.
After you stop taking a sleep medicine, you may have symptoms for 1 or 2 days such as: tiredness, trouble sleeping, nausea, flushing, lightheadedness, uncontrolled crying, vomiting, stomach cramps, panic attack, nervousness, and stomach area pain.
These are not all the side effects of ZolpiMist. Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
To report suspected adverse events or product complaints, please contact Aytu BioPharma at 855-AYTU-BIO; FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.